RQS
SVA

Ramsey Quantitative Systems’s Sinovac Biotech, Ltd SVA Stock Holding History

Ramsey Quantitative Systems’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-23,129
Closed -$150K – 3
2019
Q1 		$150K Buy
23,129
+10,970
+90% +$72.1K 0.61% 3
2018
Q4 		$84K Buy
+12,159
New +$88.8K 0.1% 261

Other funds holding SVA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAH
Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $120M AUM 52.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ramsey Quantitative Systems's SVA Position: Q2 2019 in Review

Ramsey Quantitative Systems sold out of Sinovac Biotech, Ltd (SVA) in Q2 2019, closing a stake of 23,129 shares — an estimated $150K sold.

Ramsey Quantitative Systems first reported a position in SVA in Q4 2018 and held it in 2 quarters. The position peaked at $150K in Q1 2019. 24 funds tracked by Wall St. Rank hold SVA as of Q2 2019.

  • Ramsey Quantitative Systems reported no remaining Sinovac Biotech, Ltd position as of Q2 2019 after selling out during the quarter.
  • Ramsey Quantitative Systems sold 23,129 Sinovac Biotech, Ltd shares in Q2 2019, an estimated $150K.
  • Ramsey Quantitative Systems first reported a position in Sinovac Biotech, Ltd in Q4 2018 and held it in 2 quarters.
  • Ramsey Quantitative Systems's Sinovac Biotech, Ltd position peaked at $150K in Q1 2019.
  • 24 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q2 2019.

Based on Ramsey Quantitative Systems's 13F filing for Q2 2019, filed 31 Jul 2019.